Palla Pharma Limited announced that Mr. Giles Moss has been appointed as the new Chief Executive Officer (CEO) of the Company and will assume the role on September 1, 2021. Giles brings over 30 years of commercial leadership and significant operational experience in the pharmaceutical industry to this role. Over his career, Giles has established a well-deserved reputation as both a strategic problem solver and strong business builder. In his current role of Vice President and General Manager Europe at GW Pharmaceuticals, Giles has been central to the rapid successful ex-US launch of a new highly regulated orphan medicine for epilepsy.